Leading-edge therapy targets brain chemistry of addiction
CAMH and MaRS Innovation partner on innovative approach to nicotine addiction
The experimental medication in development at
MaRS Innovation and CAMH have now entered into an agreement to collaboratively commercialize this novel therapeutic technology for applications in nicotine addiction and other applications. In the year ahead, they will design and test an optimized formulation to support further drug development.
Leading cause of death
In
For CAMH senior scientist
For MaRS Innovation, the commercial potential of the therapy is significant, especially with challenges associated with side effects around current standard-of-care therapies.
"It is clear that nicotine addiction is having devastating health and economic consequences," says
"Even though many smokers around the world want to quit, very few are able to abstain for even one year, never mind quitting all together. This newly discovered therapy, which is designed to alleviate the symptoms of withdrawal and greatly reduce the desire to smoke, is poised to make a massive impact and has already garnered significant interest from potential pharmaceutical partners."
"We are very pleased that MaRS Innovation recognized value in the highly innovative work at CAMH's Neuroscience Research Department, such as
"We are committed to aggressively build our product development and commercialization pipeline here at MaRS Innovation with exceptional technologies developed at our member institutions," adds
About MaRS Innovation
MaRS Innovation (www.marsinnovation.com) provides an integrated commercialization platform that harnesses the economic potential of the exceptional discovery pipeline of 14 leading
About CAMH
The Centre for Addiction and Mental Health (www.camh.net) is Canada's largest mental health and addiction teaching hospital, as well as one of the world's leading research centres in mental health and addiction. CAMH combines clinical care, research, education, policy development, prevention, and health promotion to help transform the lives of people affected by mental health and addiction issues. It has central facilities located in
For further information: MaRS Innovation contact: Linda Quattrin, (416) 673-8104 or [email protected]; CAMH contact: Michael Torres, (416) 595-6015 or [email protected]
Share this article